GOZZETTI ALESSANDRO

Teaching activities

Completion accademic year: 2024/2025

Course year: 1 First cycle degree (DM 270) CARDIOCIRCULATORY AND CARDIOVASCULAR PERFUSION TECHNIQUES A.Y. 2024/2025
Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2022/2023
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2021/2022

Completion accademic year: 2023/2024

Course year: 1 First cycle degree (DM 270) CARDIOCIRCULATORY AND CARDIOVASCULAR PERFUSION TECHNIQUES A.Y. 2023/2024
Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2021/2022
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2020/2021

Completion accademic year: 2022/2023

Research

Ultime pubblicazioni:

  • Gentile, M., Vigna, E., Palmieri, S., Galli, M., Derudas, D., Mina, R., et al. (2024). Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials. HAEMATOLOGICA, 109(1), 245-255 [10.3324/haematol.2023.283251]. - view more
  • Boncompagni, G., Tatangelo, V., Lopresti, L., Ulivieri, C., Capitani, N., Tangredi, C., et al. (2024). Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia. CELL DEATH & DISEASE, 15(2) [10.1038/s41419-024-06528-6]. - view more
  • Lopresti, L., Capitani, N., Tatangelo, V., Tangredi, C., Boncompagni, G., Frezzato, F., et al. (2024). p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 12 [10.3389/fcell.2024.1297116]. - view more
  • D'Agostino, M., Bertuglia, G., Rota-Scalabrini, D., Belotti, A., Morè, S., Corradini, P., et al. (2024). Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients. BLOOD, 143(7), 592-596 [10.1182/blood.2023022080]. - view more
  • Avivi, I., Vesole, D.H., Davila-Valls, J., Usnarska-Zubkiewicz, L., Olszewska-Szopa, M., Milunovic, V., et al. (2023). Outcome of second primary malignancies developing in multiple myeloma patients. CANCERS, 15(17), 1-14 [10.3390/cancers15174359]. - view more